New psychoactive substances (NPS) are a heterogeneous group of substances. They are
associated with a number of health and social harms on an individual and societal level …

Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

Cannabis has the potential to modulate some of the most common and debilitating
symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and …

Cannabinoid hyperemesis syndrome (CHS) has become more prevalent with increasing
cannabis use. CHS is often resistant to standard antiemetics. The objective of this study is to …

Background Cannabinoid hyperemesis syndrome (CHS) is a challenging clinical disorder.
CHS patients frequently present to the emergency department and may require treatment for …

New psychoactive substances (NPS) constitute a group of psychotropic substances,
designed to mimic the effects of traditional substances like cannabis, cocaine, MDMA, khat …

The term'synthetic cannabis' has been widely used in public discourse to refer to a group of
cannabinoid receptor agonists. In this paper we detail the characteristics of these drugs, and …

Cannabis sativa has a long history of use for medical purposes despite marijuana's
addictive potential. The discovery of the endogenous cannabinoid system as a …

Abstract Background The United States is faced with an unprecedented epidemic of drug
abuse. Every year thousands of Americans visit the emergency departments all over the …

Cannabinoid hyperemesis syndrome (CHS), a variant of cyclic vomiting syndrome, is an
enigmatic and challenging clinical disorder. As cannabis legalization, use, and potency has …